The DETOUR 2 Clinical Trial
NCT03119233
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
202
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Arterial Disease
Interventions
DEVICE:
DETOUR System
Sponsor
Endologix